MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Clinical outcome of subthalamic deep brain stimulation in Parkinson’s disease – The Helsinki experience

    M. Koivu, A. Huotarinen, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)

    Objective: To evaluate the efficacy and adverse effects of subthalamic deep brain stimulation (STN-DBS) in patients with advanced Parkinson's disease (PD) and the possible correlation…
  • 2016 International Congress

    A new tool to measure the impact of deep brain stimulation on Parkinson’s disease patients: Development and validation of the deep brain stimulation impairment scale (DBS-IS)

    F. Maier, C.J. Lewis, A.A. Kühn, H. Krug, J. Volkmann, A.D. Kirsch, L. Wojtecki, A. Schnitzler, G. Deuschl, J.K. Krauss, C. Woopen, L. Timmermann (Cologne, Germany)

    Objective: To develop a questionnaire that measures impairments related to deep brain stimulation (DBS). Background: DBS has considerable influence on motor and non-motor symptoms in…
  • 2016 International Congress

    MR-guided high intensity focused ultrasound in Parkinson’s disease: A series of 5 cases

    N. Wegener, G. Kaegi, R. Bauer, B. Werner, E. Martin, S.R. Schreglmann, A. Lebeda, S. Haegele-Link (St. Gallen, Switzerland)

    Objective: We present results of an ongoing trial of unilateral transcranial MR-guided high intensity focused ultrasound (tcMRgFUS) ablation of the pallido-thalamic tract (PTT, fasciculus thalamicus)…
  • 2016 International Congress

    Improving parkinsonism in DBS poor-responders by surgical lead revision of subthalamic electrodes

    R.C. Nickl, M.M. Reich, S. Johannes, F. Steigerwald, P. Fricke, V. Sturm, R.I. Ernestus, J. Volkmann, C. Matthies (Würzburg, Germany)

    Objective: If subthalamic deep brain stimulation (STN-DBS) results in poor symptom control or adverse side effects at low stimulation threshold surgical lead revision for optimal…
  • 2016 International Congress

    DBS programming requirements and longevity

    M. Tagliati, E. Karst (Los Angeles, CA, USA)

    Objective: Determine need for programming for contemporary DBS systems, and the rate of explant, revision, or replacement. Background: DBS provides relief for motor symptoms of…
  • 2016 International Congress

    Variability in the ideal target of GPi DBS for Parkinson’s disease requires advanced direct targeting for optimal results

    J.D. Hilliard, T. Morishita, M.S. Okun, K.D. Foote (Gainesville, FL, USA)

    Objective: Our findings have the potential to transform the clinical practice of surgeons who rely solely on indirect targeting, by raising awareness of the anatomic…
  • 2016 International Congress

    Articulography reveals disturbed speech motor control in ET patients treated with VIM-DBS

    M.T. Barbe, D. Mücke, A. Hermes, T.B. Roettger, J. Becker, M. Opitz, T.A. Dembek, M. Hartinger, I.G. Meister, V. Visser-Vandewalle, M. Grice, L. Timmermann (Cologne, Germany)

    Objective: We investigate the effect of VIM-DBS on speech production in patients with ET. Background: Dysarthria is a common side effect of VIM-DBS. In recent…
  • 2016 International Congress

    Safety of deep brain stimulation for movement disorders: A single-centre long-term standardized recording and analysis

    C. Bagella, D. Calandrella, G. Zorzi, G. Messina, F. Carella, A. Franzini, C.E. Marras, N. Nardocci, L.M. Romito (Milan, Italy)

    Objective: To analyze the long-term safety of Deep Brain Stimulation (DBS) procedures for patients with movement disorders. Background: DBS is currently indicated to treat several…
  • 2016 International Congress

    Mild Parkinsonian signs and TIA/stroke

    J.L. Adams, N. Dahodwala (Rochester, NY, USA)

    Objective: We aimed to determine if MPS increases TIA/stroke risk. Background: Mild Parkinsonian signs (MPS) are a syndrome of mild basal ganglia dysfunction characterized by…
  • 2016 International Congress

    Autonomic failure and circadian rhythm of arterial blood pressure in IDIOPATHIC REM behaviour disorders and Parkinson’s disease

    R. Zangaglia, E. Guaschino, N. Ghiotto, B. Minafra, M. Terzaghi, G. Capone, A. Spiritelli, D. Bosone, C. Pacchetti (Pavia, Italy)

    Objective: Aim of our study is to correlate the autonomic nervous system failure and circadian rhythm of arterial blood pressure in idiopathic REM behaviour disorders…
  • 1
  • 2
  • 3
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley